Blood Pressure Treatment for Obese Adults

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

Recruiting Phase 2 Phase 3 Interventional Study
Obesity Cardiovascular Diseases Hypertension Nocturnal Blood Pressure Natriuretic Peptides Renin-Angiotensin-Aldosterone System
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Other
Participants needed
160 (estimated)
Sponsor
University of Alabama at Birmingham · Other
Who this trial is looking for

This trial is looking for obese adults with high blood pressure. Participants will be involved in research that aims to improve blood pressure treatment timing based on body rhythms.

Are You a Good Fit for This Trial?
Rules you out Cardiovascular diseaseAngioedemaAnemia

You may be able to join if

  • I am 18 years old or older
  • My BMI is between 30 and 45
  • My blood pressure is between 130-160 over 80-100

You may not be able to join if

  • I am under 18 years old
  • My blood pressure is below 130 or above 160
  • My BMI is below 30 or above 45
  • I have a history of pulmonary hypertension
  • I have had any heart disease in the past
  • I take 3 or more blood pressure medications
  • I have significant psychiatric illness
  • I am pregnant or breastfeeding

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Obese individuals have a higher prevalence of nocturnal hypertension and non-dipping blood pressure (BP). These conditions are associated with an increased risk of cardiovascular (CV) events and death. Natriuretic Peptides (NPs) are hormones produced by the heart which directly regulate BP by causing dilation of blood vessels and by removing sodium and water from the body. NPs have a 24-hour day-n…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age more than or equal to 18 years of age * Body Mass Index between 30 to 45 kg/m\^2 * Blood pressure: Systolic BP more than or equal to 130mmHg and less than or equal to 160mmHg and diastolic blood pressure more than or equal to 80mmHg and less than or equal to 100mmHg. Indiv…
Contacts

Nehal Vekariya, MS

205-934-7173

nvekariya@uabmc.edu

CONTACT

Deborah Weber, BSN, RN

205-975-9964

dlowe@uabmc.edu

CONTACT